The information corresponding to the forthcoming edition of the programme will be updated shortly.

The online Master in Health Economics and Pharmaeconomics (MESIOL) provides specialised training in the economics and management of health services and pharmaceutical products. The master is aimed at professionals and graduates related to the health and pharmaceutical sector.

The materials have been prepared by researchers of renowned international prestige working at the UPF Research Centre on Economics and Health (CRES) and teaching staff of the Department of Economics and Business and the Department of Health Sciences at Pompeu Fabra University (Barcelona, Spain), together with other collaborators, all with proven academic and professional experience. The contents of the different modules combine an explanation of the methodological foundations with the discussion of case studies from the specialised literature.

To provide specialised training in the economics and management of health care services and pharmaceutical products (Health Economics and Pharmacoeconomics).

The concept of management in the health and the pharmaceutical sector is understood in the broadest sense. It includes public sector services, health care institutions at any level of care, providers of pharmaceutical services, agencies for the evaluation of drugs and medical technologies, the pharmaceutical industry, pharmaceutical wholesalers, insurance companies and consultancy and advisory firms.

The programme is of special relevance for professionals and graduates related to the health sector who are interested in health economics, pharmacoeconomics, and the design and management of quality programmes.

The programme offers academic training with a high reputation on the market. Participants are not required to have previous knowledge of economics.

The International Master in Health Economics and Pharmaeconomics (MESIOL) is based on three fundamental characteristics:

1. Rigorous and academic course content approached from the standpoint of economics and management.
2. The use of e-learning methods to convey knowledge, to elicit the acquisition of skills and to encourage learning.
3. Rigour in both content and working methods and continuous assessment of the knowledge acquired.

This programme is aimed at professionals in the health sector and the pharmaceutical sector who cannot afford the time to attend an on-site course, or who prefer to work primarily through virtual communication. This International Master's Degree in Health Economics and Pharmacoeconomics meets the needs and requirements both of experienced professionals and of recent graduates who wish to increase their knowledge in these areas.
The programme is geared towards professionals who, wherever they live in the world, wish to follow an online course with the characteristics we have outlined above. It is conducted entirely online, and at no time is it necessary to attend face-to-face sessions. The international edition of this programme is entirely in English.

In particular, the programme is designed to complement the training of professionals with management responsibilities and graduates interested in acquiring the necessary skills to take on such responsibilities in:

• Hospitals, clinical laboratories and public and private health centres.
• Public bodies responsible for managing and/or funding pharmaceuticals and health services.
• Private insurance companies.
• Pharmaceutical companies and companies related to the distribution of pharmaceuticals.
• Pharmaceutical and health service management training centres.
• Consultancy and advisory firms related to the health sector, etc.